Literature DB >> 9794172

Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults.

E E Calle1, T K Murphy, C Rodriguez, M J Thun, C W Heath.   

Abstract

OBJECTIVES: Diabetes mellitus and pancreatic cancer are known to be associated, but it is not known whether diabetes is a true risk factor, preceding development of the cancer, or if it is an early manifestation of the cancer. To address this uncertainty, we examined the association of pancreatic cancer mortality and reported diabetes of at least one year's duration in a large, prospective study of United States adults. The vast majority of diabetes in this cohort is likely to be non-insulin-dependent diabetes.
METHODS: After 12 years of follow-up, 2,953 deaths from pancreatic cancer were observed in a cohort of 1,089,586 men and women who were cancer-free at study entry in 1982. Cox proportional hazards models, adjusted for age, race, smoking, family history of pancreatic cancer, body mass index (wt/ht2), and education, were used to assess associations.
RESULTS: A history of diabetes was significantly related to pancreatic cancer mortality in both men (rate ratio [RR] = 1.49, 95 percent confidence interval [CI] = 1.25-1.77) and women (RR = 1.51, CI = 1.24-1.85). However, the strength of the association varied over the follow-up period. The death rate from pancreatic cancer was twice as high in diabetics as in non-diabetics during the second and third years of follow-up (adjusted RR = 2.05, CI = 1.56-2.69) but only about 40 percent higher in years nine to 12 (adjusted RR = 1.38, CI = 1.08-1.77).
CONCLUSIONS: The small but persistent increased risk of death from pancreatic cancer, seen even when the diagnosis of diabetes preceded death by many years, supports the hypothesis that diabetes may be a true, albeit modest, risk factor for pancreatic cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9794172     DOI: 10.1023/a:1008819701485

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  40 in total

1.  Regional variations in mortality rates of pancreatic cancer in China: results from 1990-1992 national mortality survey.

Authors:  Ke-Xin Chen; Peizhong Peter Wang; Si-Wei Zhang; Lian-Di Li; Feng-Zhu Lu; Xi-Shan Hao
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

2.  Diabetes Cured by Pancreaticoduodenectomy: A Case Report of Glucagonoma Masquerading as Carcinoma of the Head of Pancreas.

Authors:  Durgatosh Pandey; Hema Malini Aiyer; Rambha Pandey
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 3.  Detecting early pancreatic cancer: problems and prospects.

Authors:  Suresh T Chari
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

4.  Imaging of pancreatic cancer: An overview.

Authors:  Pavan Tummala; Omer Junaidi; Banke Agarwal
Journal:  J Gastrointest Oncol       Date:  2011-09

5.  Probability of pancreatic cancer following diabetes: a population-based study.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

6.  Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.

Authors:  Donghui Li; Yixiang Mao; Ping Chang; Chang Liu; Manal M Hassan; Saiching J Yeung; James L Abbruzzese
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

7.  Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study.

Authors:  D Harris; A Barts; J Connors; M Dahl; T Elliott; J Kong; T Keane; D Thompson; S Stafford; E Ur; S Sirrs
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

8.  Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans.

Authors:  M Mazen Jamal; Eugene J Yoon; Kenneth J Vega; Mehrtash Hashemzadeh; Kenneth J Chang
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

Review 9.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16.

Authors:  Gijs W D Landman; Nanne Kleefstra; Kornelis J J van Hateren; Klaas H Groenier; Rijk O B Gans; Henk J G Bilo
Journal:  Diabetes Care       Date:  2009-11-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.